Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Amphastar Pharmaceuticals (AMPH) Long-Term Debt Issuances (2016 - 2023)

Amphastar Pharmaceuticals has reported Long-Term Debt Issuances over the past 6 years, most recently at $345.0 million for Q3 2023.

  • Quarterly results put Long-Term Debt Issuances at $345.0 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $348.2 million (changed N/A YoY), and the annual figure for FY2023 was $845.0 million, changed.
  • Long-Term Debt Issuances for Q3 2023 was $345.0 million at Amphastar Pharmaceuticals, up from $3.2 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for AMPH hit a ceiling of $345.0 million in Q3 2023 and a floor of $3.1 million in Q1 2020.